Human HER2 expressing mouse tumor cell line MC38-HER2 was subcutaneously engrafted in human CD89 transgenic mice and the tumor bearing mice were treated with IgG, IgA, or X-body version of trastuzumab (Figure 4A). Here, CD79A is linked to neoplasm.